Placeholder

Defining a Career Path in the New Pharmaceutical Era

$30.00

Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at mwalsh@pharmavoice.com.

Product Description

Avoiding the Bull’s-Eye
When management needs to trim the workforce, there are ways to avoid being the target. The value of an employee increases if he or she has a can-do attitude, is a problem solver, and can react quickly to changes and challenges in the business environment.

    Binner. AstraZeneca. Employees need to know themselves and their passions so they can build on their strengths. We all need to remember the 70:20:10 rule of professional development: 70% of development comes from learning on the job in stretching roles; 20% comes from activities such as coaching and being mentored; and 10% comes from formal learning in the classroom or, more recently, online. To ensure longevity, employees need to make the most of these learning opportunities and take on roles that stretch and challenge them to learn new skills; they need to find a mentor and expand their networks to interact with people they can learn from, and they need to identify opportunities that keep their skills current. Working on projects is a great way to develop quickly because…

Sidebars:
Sound Bites from the Field
So, you think you want to be the boss?
The Progress of Women Executives in Pharmaceuticals and Biotechnology: A Leadership Benchmaking Study

Thought Leaders
Valerie Binner. Global Human Resources, Business Partner, Drug Development & Project Delivery, AstraZeneca, which discovers new medicines that are designed to improve the health and quality of life of patients around the world. For more information, visit astrazeneca.com.
Lisa Feldon. Partner, Healthcare Practice Leader, McCormack & Farrow, a search firm for corporate directors, C-level, division, group, and top functional executives. Ms. Feldon is also President of the HBA Southern California Chapter. For more information, visit mfsearch.com.
Nancy Lurker. CEO, PDI Inc., which provides commercialization services for established and emerging biopharmaceutical companies in three business segments: sales service, marketing service, and product commercialization. For more information, visit pdi-inc.com.
Paulo Machado. CEO and Founder, Health Innovation Partners LLC, a company committed to identifying, developing, introducing, and expediting the adoption of business solutions to drive the next-generation healthcare delivery model. For more information, visit healthinnovationpartners.com.
Robert Nauman is Principal of BioPharma Advisors Network, a community of experienced pharmaceutical professionals working together to solve key business issues for their clients that create organizational change in an efficient and profitable manner. For more information, visit biopharmaadvisors.net.
Erica Peitler, R.Ph. CEO, Erica Peitler & Associates, a firm dedicated to helping individuals and teams transform their leadership potential into leadership performance through coaching. For more information, visit ericapeitler.com.
Gregg Russo. VP, Human Resources, Daiichi Sankyo Inc., which focuses its research and development on dyslipidemia, hypertension, diabetes, thrombosis, oncology and autoimmune disease. For more information, visit dsus.com.
Pam Saras. Senior Staffing Director, Millennium: The Takeda Oncology Company, which is a global center of excellence in oncology with a robust pipeline focused on disease pathways for a variety of cancers. For more information, visit millennium.com.
Kathy Schroeder. Director, Talent Development, Astellas US LLC, an affiliate of Astellas Pharma Inc., which is dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. For more information, visit us.astellas.com. Ms. Schroeder can be e-mailed at: kathy.schroeder@us.astellas.com.
Kim Slocum is President of KDS Consulting LLC, an organization devoted to helping healthcare organizations understand the broader environment in which they operate and assisting them in finding strategic sustainable solutions to the business challenges they face. For more information, visit kimslocum.com.

FEEDBACK